Literature DB >> 20619858

VEGF/VEGFR-2 changes in frontal cortex, choroid plexus, and CSF after chronic obstructive hydrocephalus.

Jun Yang1, Stephen M Dombrowski, Abhishek Deshpande, Natalie Krajcir, Mark G Luciano.   

Abstract

Chronic hydrocephalus (CH) is often associated with decreased cerebral blood flow (CBF) and oxygen levels. While the exact pathophysiology is not clear, vascular endothelial growth factor (VEGF) and its receptor-2 (VEGFR-2) may be involved. Because the choroid plexus (CP) is involved in cerebrospinal fluid (CSF) production and secretes numerous growth factors including VEGF, it is important to understand VEGF/VEGFR-2 levels in the CP-CSF circulatory system. Our results showed significant decreases in CBF and VEGFR-2 levels in frontal cortex (FC) in CH compared with SC; there were no significant changes in VEGF levels. CBF change in FC was positively correlated with VEGFR-2 levels (P=0.024). Immunohistochemistry (IHC) showed robust expression of VEGF/VEGFR-2 in CP. After CH induction, ventricular CSF volume and VEGF levels significantly increased. These results suggest that the decreased VEGFR-2 levels in FC may be contributed to decreased CBF and increased ventricular CSF-VEGF levels possibly reflected a hypoxic response and/or accumulation of VEGF from CP secretion after blockage of CSF outlet. Further investigation into CSF-VEGF levels in different sites may provide a better understanding of VEGF/VEGFR-2 modulation in the normal and hydrocephalic brain, and may represent a feasible approach to potential therapeutic options for hydrocephalus. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20619858      PMCID: PMC2916035          DOI: 10.1016/j.jns.2010.06.012

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  40 in total

1.  Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors.

Authors:  H H Marti; W Risau
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

2.  VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature.

Authors:  Tomomi Kamba; Betty Y Y Tam; Hiroya Hashizume; Amy Haskell; Barbara Sennino; Michael R Mancuso; Scott M Norberg; Shaun M O'Brien; Rachel B Davis; Lori C Gowen; Keith D Anderson; Gavin Thurston; Shuji Joho; Matthew L Springer; Calvin J Kuo; Donald M McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-19       Impact factor: 4.733

3.  Altered formation and bulk absorption of cerebrospinal fluid in FGF-2-induced hydrocephalus.

Authors:  C E Johanson; J Szmydynger-Chodobska; A Chodobski; A Baird; P McMillan; E G Stopa
Journal:  Am J Physiol       Date:  1999-07

4.  Development and characterization of an adult model of obstructive hydrocephalus.

Authors:  M J Johnson; I Ayzman; A S Wood; J A Tkach; J Klauschie; D J Skarupa; J P McAllister; M G Luciano
Journal:  J Neurosci Methods       Date:  1999-09-15       Impact factor: 2.390

5.  Intraventricular infusion of basic fibroblast growth factor (bFGF) in the MPTP-treated common marmoset.

Authors:  R K Pearce; P Collins; P Jenner; C Emmett; C D Marsden
Journal:  Synapse       Date:  1996-07       Impact factor: 2.562

6.  Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer.

Authors:  Y Liu; S R Cox; T Morita; S Kourembanas
Journal:  Circ Res       Date:  1995-09       Impact factor: 17.367

7.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.

Authors:  F Shalaby; J Rossant; T P Yamaguchi; M Gertsenstein; X F Wu; M L Breitman; A C Schuh
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

8.  Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals.

Authors:  J Pammer; W Weninger; M Mildner; M Burian; J Wojta; E Tschachler
Journal:  J Pathol       Date:  1998-10       Impact factor: 7.996

9.  Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse.

Authors:  M Hellström; M Kalén; P Lindahl; A Abramsson; C Betsholtz
Journal:  Development       Date:  1999-06       Impact factor: 6.868

10.  Vascular endothelial growth factor induces endothelial fenestrations in vitro.

Authors:  S Esser; K Wolburg; H Wolburg; G Breier; T Kurzchalia; W Risau
Journal:  J Cell Biol       Date:  1998-02-23       Impact factor: 10.539

View more
  12 in total

1.  Stability analysis of vascular endothelial growth factor in cerebrospinal fluid.

Authors:  Jun Yang; Stephen M Dombrowski; Abhishek Deshpande; Natalie Krajcir; Serge El-Khoury; Chandra Krishnan; Mark G Luciano
Journal:  Neurochem Res       Date:  2011-06-04       Impact factor: 3.996

2.  Pattern of expression of vascular endothelial growth factor and its receptors in the ovine choroid plexus during long and short photoperiods.

Authors:  Aleksandra Szczepkowska; Barbara Wąsowska; Przemysław D Gilun; Christine Lagaraine; Vincent Robert; Laurence Dufourny; Jean-Claude Thiéry; Janina Skipor
Journal:  Cell Tissue Res       Date:  2012-05-24       Impact factor: 5.249

Review 3.  Traumatic brain injury and recovery mechanisms: peptide modulation of periventricular neurogenic regions by the choroid plexus-CSF nexus.

Authors:  Conrad Johanson; Edward Stopa; Andrew Baird; Hari Sharma
Journal:  J Neural Transm (Vienna)       Date:  2010-10-10       Impact factor: 3.575

4.  Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus.

Authors:  Ville Leinonen; Lata G Menon; Rona S Carroll; Donna Dello Iacono; Jeremy Grevet; Juha E Jääskeläinen; Peter M Black
Journal:  Int J Alzheimers Dis       Date:  2011-06-01

Review 5.  Choroid plexus in developmental and evolutionary perspective.

Authors:  Brent Roy Bill; Vladimir Korzh
Journal:  Front Neurosci       Date:  2014-11-14       Impact factor: 4.677

Review 6.  Nonsurgical therapy for hydrocephalus: a comprehensive and critical review.

Authors:  Marc R Del Bigio; Domenico L Di Curzio
Journal:  Fluids Barriers CNS       Date:  2016-02-05

Review 7.  A Review of Clinical Outcomes for Gait and Other Variables in the Surgical Treatment of Idiopathic Normal Pressure Hydrocephalus.

Authors:  Richard Shaw; Neil Mahant; Erica Jacobson; Brian Owler
Journal:  Mov Disord Clin Pract       Date:  2016-02-18

8.  Increased Vascular Endothelial Growth Factor in the Ventricular Cerebrospinal Fluid as a Predictive Marker for Subsequent Ventriculoperitoneal Shunt Infection : A Comparison Study among Hydrocephalic Patients.

Authors:  Jeong-Hyun Lee; Dong-Bin Back; Dong-Hyuk Park; Yoo-Hyun Cha; Shin-Hyuk Kang; Jung-Keun Suh
Journal:  J Korean Neurosurg Soc       Date:  2012-06-30

9.  Comparison of cerebrospinal fluid biomarkers between idiopathic normal pressure hydrocephalus and subarachnoid hemorrhage-induced chronic hydrocephalus: a pilot study.

Authors:  Jeong-Hyun Lee; Dong-Hyuk Park; Dong-Bin Back; Jea-Young Lee; Chang-In Lee; Kyung-Jae Park; Shin-Hyuk Kang; Tai-Hyoung Cho; Yong-Gu Chung
Journal:  Med Sci Monit       Date:  2012-12

Review 10.  VEGF Signaling in Neurological Disorders.

Authors:  Joon W Shim; Joseph R Madsen
Journal:  Int J Mol Sci       Date:  2018-01-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.